"International life sciences leader Anpac Bio-Medical Science Company has developed breakthrough, proprietary, ""Cancer Differentiation Analysis"" technology that effectively reinvents cancer screening and early detection. Anpac's proprietary CDA medical devices analyze simple, standard, non-invasive ""Blood Biopsies"" - resulting in measurably greater early cancer detection sensitivity and specificity, with no harmful side effects in patients. The proven results of 25,000 cases to date demonstrate CDA's research validity achieving an average sensitivity and specificity rate range of 75%-90% for ten different types of cancer -- often identifying the type and location of threatening, diseased cancer cells before they form into tumors."
{"Image Orientation": "0", "Image XResolution": "600", "Image YResolution": "600", "Image ResolutionUnit": "Pixels/Inch", "Image Software": "Adobe Photoshop CC 2015 (Macintosh)", "Image DateTime": "2016:02:10 12:57:56", "Image ExifOffset": "170", "Thumbnail Compression": "JPEG (old-style)", "Thumbnail XResolution": "600", "Thumbnail YResolution": "600", "Thumbnail ResolutionUnit": "Pixels/Inch", "Thumbnail JPEGInterchangeFormat": "296", "Thumbnail JPEGInterchangeFormatLength": "2722", "EXIF ExifImageWidth": "5999", "EXIF ExifImageLength": "1616"}